Annie Borel‐Derlon

2.1k total citations
44 papers, 1.3k citations indexed

About

Annie Borel‐Derlon is a scholar working on Hematology, Genetics and Surgery. According to data from OpenAlex, Annie Borel‐Derlon has authored 44 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Hematology, 9 papers in Genetics and 7 papers in Surgery. Recurrent topics in Annie Borel‐Derlon's work include Platelet Disorders and Treatments (27 papers), Hemophilia Treatment and Research (24 papers) and Blood Coagulation and Thrombosis Mechanisms (12 papers). Annie Borel‐Derlon is often cited by papers focused on Platelet Disorders and Treatments (27 papers), Hemophilia Treatment and Research (24 papers) and Blood Coagulation and Thrombosis Mechanisms (12 papers). Annie Borel‐Derlon collaborates with scholars based in France, United States and Germany. Annie Borel‐Derlon's co-authors include Jenny Goudemand, Thierry Lambert, Jeanne‐Yvonne Borg, Yohann Repessé, S. Claeyssens, Sébastien Lacroix‐Desmazes, Hérvè Chambost, Srini V. Kaveri, Jacqueline Conard and J. Lepercq and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

Annie Borel‐Derlon

40 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annie Borel‐Derlon France 17 1.1k 261 221 210 161 44 1.3k
A. M. Cumming United Kingdom 18 1.6k 1.4× 390 1.5× 556 2.5× 362 1.7× 228 1.4× 36 1.8k
Eugenia Biguzzi Italy 18 540 0.5× 150 0.6× 207 0.9× 120 0.6× 209 1.3× 50 929
C.F. Allaart Netherlands 14 968 0.9× 293 1.1× 587 2.7× 297 1.4× 110 0.7× 47 1.2k
Karin Kurnik Germany 15 730 0.7× 55 0.2× 118 0.5× 130 0.6× 113 0.7× 31 1.0k
Katia Paciaroni Italy 18 924 0.8× 263 1.0× 460 2.1× 376 1.8× 125 0.8× 40 1.2k
Marie-Laure Tailland France 9 829 0.7× 366 1.4× 160 0.7× 111 0.5× 38 0.2× 16 1.1k
PH Reitsma Netherlands 7 1.2k 1.0× 347 1.3× 701 3.2× 356 1.7× 123 0.8× 9 1.3k
Sylvie Ripart-Neveu France 9 793 0.7× 335 1.3× 147 0.7× 109 0.5× 26 0.2× 10 1.1k
Carol S. Wideman United States 6 1.5k 1.4× 392 1.5× 729 3.3× 513 2.4× 191 1.2× 13 1.6k
Juliana Perez Botero United States 12 310 0.3× 391 1.5× 470 2.1× 90 0.4× 152 0.9× 37 852

Countries citing papers authored by Annie Borel‐Derlon

Since Specialization
Citations

This map shows the geographic impact of Annie Borel‐Derlon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annie Borel‐Derlon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annie Borel‐Derlon more than expected).

Fields of papers citing papers by Annie Borel‐Derlon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annie Borel‐Derlon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annie Borel‐Derlon. The network helps show where Annie Borel‐Derlon may publish in the future.

Co-authorship network of co-authors of Annie Borel‐Derlon

This figure shows the co-authorship network connecting the top 25 collaborators of Annie Borel‐Derlon. A scholar is included among the top collaborators of Annie Borel‐Derlon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annie Borel‐Derlon. Annie Borel‐Derlon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roule, Vincent, P Ardouin, Yohann Repessé, et al.. (2018). Point of Care Tests VerifyNow P2Y12 and INNOVANCE PFA P2Y Compared to Light Transmittance Aggregometry After Fibrinolysis. Clinical and Applied Thrombosis/Hemostasis. 24(7). 1109–1116. 6 indexed citations
2.
Borel‐Derlon, Annie, Jenny Goudemand, Dominique Desprez, et al.. (2018). Who Are the Type 2 Von Willebrand Disease Patients? Results from Interim Analysis of the French HRQoL Study: Wish-Qol.. Blood. 132(Supplement 1). 2468–2468.
3.
Négrier, Claude, A.‐S. Ducloy‐Bouthors, Vincent Piriou, et al.. (2017). Postauthorization safety study of Clottafact®, a triply secured fibrinogen concentrate in acquired fibrinogen deficiency: a prospective observational study. Vox Sanguinis. 113(2). 120–127. 8 indexed citations
4.
Vautier, Mathieu, Hubert de Boysson, Christian Créveuil, et al.. (2016). Influence of factor VIII level and its inhibitor titer on the therapeutic response to corticosteroids alone in the management of acquired hemophilia. Medicine. 95(48). e5232–e5232. 12 indexed citations
5.
Rauch, Antoine, Claudine Caron, Flavien Vincent, et al.. (2016). A novel ELISA-based diagnosis of acquired von Willebrand disease with increased VWF proteolysis. Thrombosis and Haemostasis. 115(5). 950–959. 9 indexed citations
6.
Dargaud, Yesim, Anna Pavlova, Sébastien Lacroix‐Desmazes, et al.. (2016). Achievements, challenges and unmet needs for haemophilia patients with inhibitors. Haemophilia. 22(S1). 1–24. 15 indexed citations
7.
Repessé, Yohann, Ivan Peyron, Jordan D. Dimitrov, et al.. (2013). Development of inhibitory antibodies to therapeutic factor VIII in severe hemophilia A is associated with microsatellite polymorphisms in the HMOX1 promoter. Haematologica. 98(10). 1650–1655. 27 indexed citations
8.
Gautier, Philippe, et al.. (2012). Hydrolysis of factor VIII mediated by catalytic antibodies occurs in haemophilia A patients with or without factor VIII inhibitors. Haemophilia. 19(2). 322–329. 1 indexed citations
9.
d’Oiron, Roseline, Virginie Demiguel, Annie Borel‐Derlon, et al.. (2011). Environmental Risk Factors of Inhibitor in Mild/Moderate Hemophilia A Patients Included in the FranceCoag Network. Blood. 118(21). 1213–1213. 1 indexed citations
10.
Guérois, C, Annie Borel‐Derlon, Pascal Guillon, et al.. (2010). Patient resources in the therapeutic education of haemophiliacs in France: their skills and roles as defined by consensus of a working group. Haemophilia. 16(3). 447–454. 14 indexed citations
11.
Wootla, Bharath, Jordan D. Dimitrov, Alain Friboulet, et al.. (2009). Factor VIII‐hydrolyzing IgG in acquired and congenital hemophilia. FEBS Letters. 583(15). 2565–2572. 16 indexed citations
12.
Gautier, Philippe, et al.. (2009). Le syndrome de Willebrand acquis : du diagnostic au traitement. Pathologie Biologie. 57(7-8). 536–542. 3 indexed citations
13.
Wootla, Bharath, Suryasarathi Dasgupta, Jordan D. Dimitrov, et al.. (2008). Factor VIII Hydrolysis Mediated by Anti-Factor VIII Autoantibodies in Acquired Hemophilia. The Journal of Immunology. 180(11). 7714–7720. 39 indexed citations
14.
Repessé, Yohann, M. Slaoui, Philippe Gautier, et al.. (2007). Factor VIII (FVIII) gene mutations in 120 patients with hemophilia A: detection of 26 novel mutations and correlation with FVIII inhibitor development. Journal of Thrombosis and Haemostasis. 5(7). 1469–1476. 42 indexed citations
15.
d’Oiron, Roseline, J. Reynaud, Kathelijne Peerlinck, et al.. (2006). Impact of Choice of Treatment for Bleeding Episodes on Inhibitor Outcome in Patients With Mild/Moderate Hemophilia A and Inhibitors. Seminars in Hematology. 43(1 Suppl 1). S3–S9. 18 indexed citations
16.
Goudemand, Jenny, I. Scharrer, Erik Berntorp, et al.. (2005). Pharmacokinetic studies on Wilfactin®, a von Willebrand factor concentrate with a low factor VIII content treated with three virus-inactivation/removal methods. Journal of Thrombosis and Haemostasis. 3(10). 2219–2227. 64 indexed citations
17.
Lambert, Thierry, et al.. (2004). Intestinal surgery with activated recombinant factor VII prophylaxis in patients with haemophilia A and high responding inhibitors. Blood Coagulation & Fibrinolysis. 15(8). 687–691. 12 indexed citations
18.
Lepercq, J., Jacqueline Conard, Annie Borel‐Derlon, et al.. (2001). Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies. BJOG An International Journal of Obstetrics & Gynaecology. 108(11). 1134–1140. 195 indexed citations
19.
Borel‐Derlon, Annie. (1998). Quelles stratégies thérapeutiques périopératoires dans les maladies constitutionnelles de l'hémostase?. Annales Françaises d Anesthésie et de Réanimation. 17. 10s–13s. 1 indexed citations
20.
Lefrançois, C, Laurent Dubus, Joan Maurel, et al.. (1997). Hémorragie digestive révélatrice d'une angiodysplasie et d'une maladie de von Willebrand de type 2. Annales Françaises d Anesthésie et de Réanimation. 16(8). 978–981. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. M. Cumming Breakdown of academic impact, for papers by Eugenia Biguzzi Breakdown of academic impact, for papers by C.F. Allaart Breakdown of academic impact, for papers by Karin Kurnik Breakdown of academic impact, for papers by Katia Paciaroni Breakdown of academic impact, for papers by Marie-Laure Tailland Breakdown of academic impact, for papers by PH Reitsma Breakdown of academic impact, for papers by Sylvie Ripart-Neveu Breakdown of academic impact, for papers by Carol S. Wideman Breakdown of academic impact, for papers by Juliana Perez Botero
Rankless by CCL
2026